Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sakar Healthcare operates as a fully integrated pharmaceutical manufacturer with EU GMP-approved facilities for both general and oncology products. The company has developed 30 generic anti-cancer molecules with technology transfer to its manufacturing units. It has completed regulatory requirements such as CTD dossiers and bioequivalence studies for global markets. Its oncology unit received EU GMP approval in March 2024 for oral solid dosage forms and injections—enabling exports to Europe. The company’s product portfolio spans multiple therapeutic areas with commercialized products exported globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sakar Healthcare.